133 related articles for article (PubMed ID: 6377829)
1. Extrapancreatic effects of a sulphonylurea. Decrease in xylose absorption by glipizide in type II diabetics.
Kollind M; Adamson U; Lins PE; Ohlsén P
Acta Med Scand; 1984; 215(5):443-5. PubMed ID: 6377829
[TBL] [Abstract][Full Text] [Related]
2. Glipizide does not affect absorption of glucose and xylose in diabetics without residual beta-cell function.
Lins PE; Kollind M; Adamson U
Acta Med Scand; 1986; 219(2):189-93. PubMed ID: 3515865
[TBL] [Abstract][Full Text] [Related]
3. The acute effect of preprandial exogenous and endogenous sulphonylurea-stimulated insulin secretion on postprandial glucose excursions in patients with type 2 diabetes.
Groop PH; Melander A; Groop LC
Diabet Med; 1993; 10(7):633-7. PubMed ID: 8403824
[TBL] [Abstract][Full Text] [Related]
4. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
Ahrén B; Lundquist I; Scherstén B
Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592
[TBL] [Abstract][Full Text] [Related]
5. Forearm insulin uptake in healthy subjects after oral glucose and intravenous glipizide.
Nygren A; Lindblad LE; Sundblad L
Acta Endocrinol (Copenh); 1981 Nov; 98(3):407-12. PubMed ID: 7027714
[TBL] [Abstract][Full Text] [Related]
6. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
Groop L; Tötterman KJ
Acta Endocrinol (Copenh); 1982 Jul; 100(3):410-5. PubMed ID: 7051722
[TBL] [Abstract][Full Text] [Related]
7. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.
Scheen AJ; Lefebvre PJ; Luyckx AS
Eur J Clin Pharmacol; 1984; 26(4):471-4. PubMed ID: 6376145
[TBL] [Abstract][Full Text] [Related]
8. Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.
Sartor G; Ursing D; Nilsson-Ehle P; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1987; 33(3):279-82. PubMed ID: 3319648
[TBL] [Abstract][Full Text] [Related]
9. Glipizide and hepatic glycogenolysis.
Bloch K; Daturi S; Tommasini R
Acta Endocrinol Suppl (Copenh); 1980; 239():11-4. PubMed ID: 7001838
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.
Pentikäinen PJ; Neuvonen PJ; Penttilä A
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):98-107. PubMed ID: 6341263
[TBL] [Abstract][Full Text] [Related]
11. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
[TBL] [Abstract][Full Text] [Related]
12. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of glucose and lactate after intravenous glipizide administration in some insulin-dependent diabetics. Therapeutic effects of an associated glipizide-insulin treatment.
Giampietro O; Navalesi R; Buzzigoli G; Boni C
Curr Med Res Opin; 1979; 6(5):325-30. PubMed ID: 396109
[TBL] [Abstract][Full Text] [Related]
14. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
Bitzén PO; Melander A; Scherstén B; Wåhlin-Boll E
Eur J Clin Pharmacol; 1988; 35(1):31-7. PubMed ID: 3065086
[TBL] [Abstract][Full Text] [Related]
15. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
Wåhlin-Boll E; Melander A; Sartor G; Scherstén B
Eur J Clin Pharmacol; 1980 Oct; 18(3):279-83. PubMed ID: 7002565
[TBL] [Abstract][Full Text] [Related]
16. Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study.
Groop LC; Ratheiser K; Luzi L; Melander A; Simonson DC; Petrides A; Bonadonna RC; Widén E; DeFronzo RA
Acta Diabetol; 1991; 28(2):162-8. PubMed ID: 1777653
[TBL] [Abstract][Full Text] [Related]
17. [Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)].
Azzopardi J; Campbell IW; Clarke BF; Duncan LJ
Med Klin; 1975 Jul; 70(28-29):1214-8. PubMed ID: 809650
[TBL] [Abstract][Full Text] [Related]
18. Nitrochalcones: potential in vivo insulin secretagogues.
Damazio RG; Zanatta AP; Cazarolli LH; Mascarello A; Chiaradia LD; Nunes RJ; Yunes RA; Silva FR
Biochimie; 2009; 91(11-12):1493-8. PubMed ID: 19747522
[TBL] [Abstract][Full Text] [Related]
19. Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine.
Connacher AA; el Debani AH; Isles TE; Stevenson IH
Eur J Clin Pharmacol; 1987; 33(1):81-3. PubMed ID: 3319639
[TBL] [Abstract][Full Text] [Related]
20. Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.
Putnam WS; Andersen DK; Jones RS; Lebovitz HE
J Clin Invest; 1981 Apr; 67(4):1016-23. PubMed ID: 7009650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
